ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 170 filers reported holding ARGENX SE in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $732 | +94.7% | 1,489 | +54.6% | 0.01% | +150.0% |
Q2 2023 | $376 | +0.8% | 963 | -4.0% | 0.00% | -33.3% |
Q1 2023 | $373 | +46.9% | 1,003 | +49.3% | 0.00% | +50.0% |
Q4 2022 | $254 | -99.3% | 672 | +505.4% | 0.00% | – |
Q3 2022 | $39,000 | -7.1% | 111 | 0.0% | 0.00% | – |
Q2 2022 | $42,000 | +61.5% | 111 | +33.7% | 0.00% | – |
Q1 2022 | $26,000 | -21.2% | 83 | -12.6% | 0.00% | – |
Q4 2021 | $33,000 | +13.8% | 95 | 0.0% | 0.00% | – |
Q3 2021 | $29,000 | +70.6% | 95 | +72.7% | 0.00% | – |
Q2 2021 | $17,000 | +30.8% | 55 | +12.2% | 0.00% | – |
Q1 2021 | $13,000 | -7.1% | 49 | +4.3% | 0.00% | – |
Q4 2020 | $14,000 | -64.1% | 47 | -68.7% | 0.00% | – |
Q3 2020 | $39,000 | +129.4% | 150 | +16.3% | 0.00% | – |
Q2 2020 | $17,000 | 0.0% | 129 | 0.0% | 0.00% | – |
Q1 2020 | $17,000 | -15.0% | 129 | +5.7% | 0.00% | – |
Q4 2019 | $20,000 | +33.3% | 122 | -10.3% | 0.00% | – |
Q3 2019 | $15,000 | -21.1% | 136 | +3.0% | 0.00% | – |
Q2 2019 | $19,000 | +18.8% | 132 | 0.0% | 0.00% | – |
Q1 2019 | $16,000 | +6.7% | 132 | -17.5% | 0.00% | – |
Q4 2018 | $15,000 | – | 160 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |